Cancer by hormone therapy at the beginning of menopause

Women who start hormone replacement therapy while they start the menopause , have a higher risk of developing breast cancer, compared to women who start therapy after, publishes the Journal of the National Cancer Institute.

The study was conducted in more than one million British women and noted that those that They waited 5 years or more to start hormone therapy they had little or no risk of breast cancer. But the ones that started while entering the menopause They had 43% more risk.

The results were compared with American studies, which found that women who started hormone replacement therapy Just at menopause they were 41% more likely to develop breast cancer than those who waited, said the Dr. Rowan Chlebowski , of the Angels BioMedical Research Institute Y Garnet Anderson of the Fred Hutchinson Cancer Research Center in Seattle.

Before 2002, doctors used to prescribe hormone therapy to decrease the risk of heart disease and osteoporosis, risks that increase during menopause, as well as to remove symptoms such as hot flashes.

After the studies of Women's Health Initiative which proved to increase the risk of cancer and heart attack sales of hormone treatments fell sharply. Subsequent studies showed that the rate of breast cancer among adult women fell 10% after 2002.

If you are a woman with Heart problems , you should consult your doctor about the intake of hormones, since some doctors point out that the opposite happens in women who suffer from heart disease. Those who start hormone replacement therapy sooner have less risk than women who start later.

Source: Reuters


Video Medicine: Menopause and Midlife Health (Hormone Therapy) (March 2024).